Integrating Clinical Operations and Pharmacovigilance for Safer Trials

Clinical operations and pharmacovigilance are often managed in parallel — but in early-phase and complex trials, that separation can create avoidable risk. Delayed safety decisions, protocol amendments, inconsistent safety data handling, and added pressure on sites can directly affect both patient safety and development timelines.

In this on-demand webinar, experts from Ergomed Clinical Research and PrimeVigilance explore how earlier integration across clinical operations, medical monitoring, and pharmacovigilance can strengthen study oversight from the outset.

Key takeaways include:

• Why separating clinical operations and safety oversight creates avoidable risk in clinical development
• The role of physician-led medical review in early and complex clinical trials
• What integrated planning looks like across study design, medical monitoring, pharmacovigilance, and trial conduct
• How earlier collaboration can support stronger decision-making, operational readiness, and timeline protection
• Practical ways to reduce downstream risk while improving both patient safety and study efficiency

In complex clinical development, patient safety and operational delivery are deeply connected. A more integrated clinical and safety strategy helps sponsors anticipate risk earlier, make better benefit-risk decisions, and protect trial timelines.

Watch the webinar to learn how an integrated approach to medical review, medical monitoring, and pharmacovigilance can strengthen study oversight from the outset.

 

“Medical review goes beyond individual case assessment—it requires understanding the evolving safety profile of a product through accumulated clinical and safety data.”

Dr. Cvijeta Bielen, Executive Medical Director, PrimeVigilance

Please enter your details to get access to the content